Position in SLDB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$429,130
-$1,474,614 QoQ
Shares Held
42,956
-83.8% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#86
of 155 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLDB Over Time
Shares Held
Position Value (USD)
Derivatives in SLDB
reported options exposure · as of Dec 31, 2025CallValue
$2,391,360
CallShares
424,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. SLDB ranks #85 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
328,635 | $43,793,900 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
1,059,730 | $41,287,080 | |
| 3 | ALMS |
Alumis Inc.
|
870,548 | $24,497,220 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
72,842 | $24,386,773 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
388,682 | $22,594,084 | |
| 6 | CLDX |
Celldex Therapeutics, Inc.
|
478,500 | $17,804,985 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
504,559 | $15,555,553 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
2,148,359 | $14,866,644 |
All Filings in SLDB
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $429,130 | 42,956 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,903,744 | 264,409 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,391,360 | 424,000 | Call | Sole | 2026-02-18 | |
| 2025-12-31 | $904,706 | 160,409 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $2,887,560 | 468,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $1,090,177 | 176,690 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $851,000 | 230,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,200,000 | 300,000 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $2,091,000 | 300,000 | Call | Sole | 2024-11-14 | |
| 2022-03-31 | $625,386 | 521,155 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $912,021 | 521,155 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,245,560 | 521,155 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,472,970 | 675,675 | Shares | Sole | 2021-08-18 | |
| 2021-03-31 | $130,602 | 23,617 | Shares | Sole | 2021-08-18 | |
| 2020-12-31 | $5,973,100 | 788,008 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,599,656 | 788,008 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,308,863 | 788,008 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,288,336 | 539,053 | Shares | Sole | 2020-05-15 | |
| 2020-03-31 | $1,075,022 | 449,800 | Call | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||